@article{308e48539cf243e798542801e63d343e,
title = "Severe disease activity in MS patients treated with cladribine after fingolimod withdrawal",
keywords = "Breakthrough disease activity, Cladribine, Fingolimod withdrawal, Multiple sclerosis",
author = "Maria Cellerino and Simona Bonavita and Margherita Ferrero and Matilde Inglese and Giacomo Boffa",
note = "Funding Information: Drs. Cellerino and Ferrero report no disclosures; Dr. Bonavita has received speaker honoraria and advisory boards fees from Novartis, Almirall, Roche, Merck-Serono, Biogen, Teva and Genzyme. M. Inglese: received research grants from NIH, DOD, NMSS, FISM, and Teva Neuroscience. Dr. Boffa reports no disclosures. ",
year = "2020",
month = nov,
day = "15",
doi = "10.1016/j.jns.2020.117156",
language = "English",
volume = "418",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
}